Home Newsletters Cell Therapy News Peripheral Leukemia Burden at Time of Apheresis Negatively Affects the Clinical Efficacy...

Peripheral Leukemia Burden at Time of Apheresis Negatively Affects the Clinical Efficacy of CART19 in Refractory or Relapsed B-ALL

0
Scientists retrospectively analyzed 143 patients treated with CART19 to evaluate the effect of peripheral leukemia burden at time of apheresis.
[Molecular Therapy-Methods & Clinical Development]

Sorry, but the selected Zotpress account can't be found.

AbstractFull ArticleGraphical Abstract
Exit mobile version